Physician

James Craig Azurin, MD MS

According to 2025 Medicare claims, James Azurin, MD MS (NPI: 1932182649) practices neurology in the Rochester, NY market, with the plurality of this provider's patient population coming from Monroe, NY. This provider's primary affiliated billing organization is GREATER ROCHESTER NEUROLOGICAL ASSOCIATES, PC (NPI: 1902852908; TIN: 161128265) and primary practice location at 14618-5659. Azurin is affiliated with the Rochester Regional Health ACO, Inc. (ACO ID: A3476), participating under the MSSP model.

Azurin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 180 traditional Medicare patients, billed 23,644 HCPCS/CPT codes, and received $569,159 in Medicare payments. The top billing code was 95910 (Nerve conduction, 7-8 studies). Part D data shows 1,995 prescription claims across 310 beneficiaries totaling $2,255,786 in drug costs, led by Avonex Pen (4 Pack) (Interferon Beta-1a). 2019 DME data shows 12 claims. Open Payments data shows 157 records totaling $3,127. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $120,852 to $569,159. Similarly, Part D prescription costs have moved sharply higher in recent years, from $778,075 to $2,255,786. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	231	3,057	$120,852
2016	224	7,332	$171,425
2017	239	12,748	$179,842
2018	201	10,850	$122,995
2019	186	8,282	$112,485
2020	194	26,430	$426,728
2021	198	23,857	$472,801
2022	165	25,670	$499,147
2023	186	25,845	$616,550
2024	180	23,644	$569,159

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	206	1,791	$778,075
2016	183	1,703	$930,060
2017	204	1,747	$807,715
2018	219	1,617	$928,193
2019	221	1,624	$882,702
2020	272	1,761	$1,355,309
2021	335	2,457	$2,714,642
2022	330	2,947	$3,912,616
2023	309	2,415	$2,618,663
2024	310	1,995	$2,255,786

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	16	19	$1,121
2016	17	18	$1,244
2017	12	13	$797
2018	N/R	N/R	N/R
2019	11	12	$765
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95910	Nerve conduction, 7-8 studies	21	21	$133
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	55	55	$108
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	109	160	$85
95886	Needle measurement of electrical activity in arm or leg muscles, complete study	43	74	$73
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	38	48	$58

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Avonex Pen (4 Pack)	Interferon Beta-1a	35	1,036	$318,676
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	27	804	$315,816
Teriflunomide	Teriflunomide	78	2,580	$302,041
Copaxone	Glatiramer Acetate	30	1,088	$221,225
Glatopa	Glatiramer Acetate	65	1,844	$161,155

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	157	$3,127	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for James Craig Azurin, MD MS?

Tedicare shows public-source Medicare data for James Craig Azurin, MD MS (NPI 1932182649), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Craig Azurin, MD MS have ACO affiliation data?

James Craig Azurin, MD MS is shown with ACO affiliation data for Rochester Regional Health ACO, Inc. (MSSP, ACO ID A3476).

What billing organization is linked to James Craig Azurin, MD MS?

James Craig Azurin, MD MS is linked to GREATER ROCHESTER NEUROLOGICAL ASSOCIATES, PC (billing NPI 1902852908) in the available physician profile data.

Does James Craig Azurin, MD MS have Open Payments data?

James Craig Azurin, MD MS has 157 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.